For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Blog
FDA Issues Commonsense Federal Guidance on Nutrition Labeling
While it might not be ideal, it’s an improvement on the former scenario—a sprinkling of common sense on an otherwise foolish regulation.
Letters
CEI Joins Coalition Letter Supporting Cutting-Edge Technologies for Less Harmful Tobacco Products
View Full Document as PDF Dear Commissioner Gottlieb, We the undersigned organizations dedicated to improving public health, increasing consumer choice, and reducing…
U.S. News & World Report
Don’t Blunt the Marijuana Revolution
U.S. News & World Report covers the coalition letter, led by CEI, advocating for the Rohrabacher medical marijuana amendment. America is undergoing a somewhat…
HuffPost
Activists Use Faulty Claims to Push Flame Retardant Ban
“Look before you leap” has long been considered sage advice. But environmental activists today called on regulators at the Consumer Product Safety Commission (CPSC) to…
Blog
Ohio Drug Price Initiative Gives Taxpayer Money to Unnecessary Lawyers
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.
Blog
Conservatives & Libertarians to GOP: Time to Evolve on Marijuana Policy
A bill introduced by Rep. Dana Rohrabacher (R-CA) and Rep. Earl Blumenauer (D-OR) will prevent the Department of Justice from using taxpayer dollars to prosecute medical marijuana…